m.lokken
Submits third-party assay reports on material purchased directly. Based in Trondheim.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
98.91%
n=7
Suppliers covered
6
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042386 | Tirzepatide | Homopeptide | HOMO-2601-N4081 | Janoshik | 2026-Q2 | 98.90 | 4.85 | 105.6 | Buyer-sourced | 0 | PASS |
| AX-2025-019746 | GHRP-2 | Homopeptide | HOMO-2505-T3389 | Janoshik | 2025-Q4 | 99.59 | 4.69 | 105.4 | Buyer-sourced | 0 | PASS |
| AX-2025-019445 | N-Acetyl Semax Amide | JEEP | JEEP-2507-U8215 | PeptideMeter | 2025-Q4 | 99.93 | 9.21 | 107.3 | Buyer-sourced | 0 | PASS |
| AX-2025-020936 | Semaglutide | WXT | WXT-2505-E2684 | VendorInvestigate | 2025-Q4 | 97.90 | 2.63 | 107.0 | Buyer-sourced | 0 | PASS |
| AX-2025-018949 | Retatrutide | ASY | ASY-{CAT}-1860 | Janoshik | 2025-Q3 | 98.06 | 6.06 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019916 | Ipamorelin | HJ | HJ-2504-X6056 | Janoshik | 2025-Q3 | 99.82 | 7.43 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005118 | Tirzepatide | SGN | SGN-2411-N9012 | Janoshik | 2024-Q4 | 98.91 | 3.31 | 93.4 | Buyer-sourced | 0 | PASS |